gross revenue1 of $28.75 million, up 37 percent on the same period last year. Bubs® Infant Formula was the key driver of growth with attributable gross revenues up 77 percent compared to the prior corresponding period (pcp). Revenue of adult goat milk powder have also increased 30 percent over the same period.
still an EBITDA loss of $3.74
looks like they have a bright future, just a bit worried what this EBITDA loss will do to the stock price today... even though its because they are spending more to make the company grow.
Ann: Bubs Australia - Half Year Results Presentation, page-2
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $124.8M | |||
| Open | High | Low | Value | Volume |
| 14.5¢ | 14.5¢ | 14.0¢ | $209.1K | 1.461M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1257458 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 1284404 | 24 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
14.3¢ |
Change
0.000 ( 1.35 %) |
||||
| Open | High | Low | Volume | ||
| 14.5¢ | 14.5¢ | 14.0¢ | 1470542 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| BUB (ASX) Chart |